Hologic, Inc. Aptima HCV Quant Dx Assay Kits

The Florida Department of Health (FDOH), Bureau of Public Health Laboratories (BPHL) is seeking to procure FDA-approved Hepatitis C Virus (HCV) qualitative and quantitative assay kits that are compatible with the department's existing Panther instrumentation system used by the BPHL Serology Unit. The FDOH BPHL has identified Hologic, Inc. as the sole distributor and manufacturer of the Aptima HCV Quant Dx Assay Kits, which are the only FDA-approved HCV assay product compatible with the department's existing equipment. The intended contract term is 3 years, with an estimated total value of $1,170,000. The posting will remain active until November 30, 2022, and the FDOH BPHL is requesting authorization to purchase the Hologic Aptima HCV Quant Dx Assay Kits as a single source acquisition in accordance with Florida Administrative Code.

This opportunity is open to all qualified vendors, but Hologic, Inc. has been identified as the sole source provider based on the compatibility of their Aptima HCV Quant Dx Assay Kits with the FDOH BPHL's existing Panther instrumentation system. There are no set-aside designations or restrictions on the types of organizations that can respond. The FDOH BPHL is the only agency involved in this procurement, which will be limited to the jurisdiction of Leon County, Florida.